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2Abstract
This study aims to examine the association between change in physical activity levels over
time and accumulation of cardiometabolic risk factors. Four consecutive surveys (Time 1 to 4)
were conducted with 4-year intervals in 1997–2013 (the Finnish Public Sector study). Physical
activity of 15,634 cardio-metabolically healthy participants (mean age 43.3 (SD 8.7) years,
85% women) was assessed using four-item survey measure and was expressed as weekly
metabolic equivalent (MET) hours in Time 1, 2, and 3. At each time point, participants were
categorised into low (<14 MET-h/week), moderate (≥14 to <30 MET-h/week), or high (≥30
MET-h/week) activity level and change in physical activity levels between Time 1 and 3 (over
8-years) was determined. The outcome was the number of incident cardiometabolic risk factors
(hypertension, dyslipidemia, diabetes, and obesity) at Time 4. Cumulative logistic regression
was used for data analysis. Compared to maintenance of low physical activity, increase in
physical activity from low baseline activity level was associated with decreased accumulation
of cardiometabolic risk factors in a dose-response manner (cumulative odds ratio [cOR]=0.73,
95% CI 0.59-0.90 for low-to-moderate and cOR=0.67, 95% CI 0.49-0.89 for low-to-high, P
for trend 0.0007). Decrease in physical activity level from high to low was associated with
increased accumulation of cardiometabolic risk factors (cOR=1.60, 95% CI 1.27-2.01)
compared to those who remained at high activity level. Thus even a modest long-term increase
in physical activity was associated with reduction in cardiometabolic risk whereas decrease in
physical activity was related to increased risk.
3Introduction
Physical inactivity has been ranked among the top risk factors for global burden of disease and
mortality (GBD 2015 Mortality and Causes of Death Collaborators, 2016; GBD 2015 Risk
Factors Collaborators et al., 2016). Physically inactive individuals have a higher risk for
cardiovascular morbidity and mortality compared to those who are physically active (Physical
Activity Guidelines Advisory Committee, 2008; Shiroma and Lee, 2010; Warburton et al.,
2010). Meta-analyses have additionally shown that there is a dose-response relationship
between higher levels of self-reported leisure time physical activity and reduced incidence of
coronary heart disease (CHD) and stroke (Li et al., 2013; Li and Siegrist, 2012). However,
most studies have measured physical activity at one time point only. The extent to which long-
term changes, both increases and decreases, in physical activity may affect health outcomes
remains unclear (Andersen, 2004; Shortreed et al., 2013).
Studies suggest that changes in physical activity during mid-life or later life are common and
that the changes in physical activity are associated with the changes in body weight, waist
circumference, blood pressure, and lipids (Aadahl et al., 2009; Balkau et al., 2006; Byberg et
al., 2001). In addition, increase in physical activity has been found to be associated with a
lower, and a decrease in physical activity with a higher mortality and cardiac event risk, when
compared to unchanged activity (Byberg et al., 2009; Manson et al., 1999; Paffenbarger et al.,
1993; Petersen et al., 2012; Wannamethee et al., 1998). However, associations between
changes in physical activity over extended periods of time and accumulation of incident
cardiovascular risk factors remain poorly characterized.
In this study, we examined whether change in physical activity level is associated with
subsequent accumulation of incident hypertension, dyslipidemia, diabetes, and obesity in
healthy adults. To capture long-term changes in physical activity, we used repeated data on
physical activity over eight years.
4Methods
Study population. The study population consisted of participants of the Finnish Public Sector
(FPS) study which is an ongoing cohort study on employees of ten towns and six hospital
districts (Kivimäki et al., 2007). Survey questionnaires were sent to all current employees of
the target organizations as well as those who had earlier participated in the surveys. The
participants were from a wide range of occupations from semi-skilled cleaners to physicians
and mayors. The FPS has been approved by the ethics committee of the Hospital District of
Helsinki and Uusimaa.
In this study we used data from four consecutive surveys conducted in 4-year intervals in
1997/98 (Time 1), 2000/02 (Time 2), 2004/05 (Time 3), and 2008/09 (Time 4), or, in 2000/02
(Time 1), 2004/05 (Time 2), 2008/09 (Time 3), and 2012/13 (Time 4). Overall 26,245
participants responded to all four consecutive surveys from Time 1 to 4. We included only
those participants who had no missing data on physical activity from Time 1 to 3, no missing
data on cardiometabolic risk factors at Time 3 and 4, and who were free from major
cardiovascular events and cardiometabolic risk factors at Time 3. This resulted in an analytical
sample of 15,634 cardio-metabolically healthy participants (mean age 43.3 (SD 8.7) years, 85%
women) (Figure 1). The study design is illustrated in Figure 2.
At Time 1, mean age did not differ between the study population (respondents to 4 consecutive
study waves; N=15,634) and the baseline eligible population of 75,572 cohort participants
(43.3 (SD 8.7) vs. 43.7 (SD 9.6) years, respectively). There were more women (85% vs. 76%)
and less low educated participants (8% vs. 16%) in the study population vs. eligible population.
Physical activity assessment. Physical activity was assessed identically with four-item survey
measure at Time 1, 2, and 3. The respondents were asked to estimate their average weekly
hours of both leisure-time and commuting physical activity/exercise within the preceding year
in four different intensity level: walking, brisk walking, jogging, and running, or activities with
equivalent intensities (Lahti et al., 2010). Each intensity level had five response alternatives of
which the class mid-points were used to calculate the time spent in each intensity level: no
activity, less than 0.5 hours (15 min used for calculation), ~1 hour (45 min), 2-3 hours (2.5 h),
and ≥ 4 hours/week (5 h). Time spent on activity at each intensity level in hours per week was
multiplied by the average energy expenditure of each activity and expressed as Metabolic
Equivalent (MET). We used the latest available MET-values for each intensity level: walking,
brisk walking, jogging, and running corresponded to 3.5, 5, 8, and 11 METs, respectively
5(Ainsworth et al., 2011). The amount of physical activity, including both leisure-time and
commuting activity, was quantified as weekly MET-hours (Kujala et al., 1998) by summing up
the amount of activity at each intensity level together.
The mean of amount of physical activity at Time 1 and Time 2 was used to define the baseline
activity level in order to take into account the phenomenon of regression to the mean (Chiolero
et al., 2013). The amount of physical activity at Time 3 was used to define the follow-up
physical activity level. The participants were categorized into low (<14 MET-h/week),
moderate (≥14 to <30 MET-h/week), and high (≥30 MET-h/week) activity levels at baseline
and at Time 3. This allowed us to identify individuals who either remained at their baseline
activity level or increased or decreased their activity by Time 3 (Figure 2).
We choose the cut-point of 14 MET-h/week because physical activity higher than 14 MET-
h/week has been shown to be associated with CHD (Tanasescu et al., 2000) and mortality
(Arem et al., 2015; Moore et al., 2012). The activity of 30 MET-h/week is showed to be needed
for weight management (Fogelholm et al., 2005).
Assessment of cardiometabolic risk factors. Incident hypertension, dyslipidemia, and
diabetes were derived from national registers, and incident obesity was defined as body mass
index (BMI) ≥30 kg/m2 from the self-reported body weight and height. We used data on
prescription purchases of antihypertensive, lipid-lowering (statins), and antidiabetic
medication to identify cases of hypertension, dyslipidemia, and diabetes, respectively (Halonen
et al., 2015). In Finland, drugs for the treatment of these conditions are available by prescription
only. All residents are covered by national health insurance, which provides reimbursement for
the drugs included in this study and all the reimbursed prescriptions are registered in the Finnish
Prescription Register managed by the Social Insurance Institution. For each drug prescription,
the dispensing date, the World Health Organization Anatomic Therapeutic Chemical (ATC)
code, and the Defined Daily Dosages (DDD) (World Health Organisation, n.d.) were recorded.
For antihypertensive medication we used ATC codes C02, C03, C07, C08, and C09; for statins
code C10AA, and for antidiabetic drugs code A10. Participants having hypertension or type 2
diabetes were additionally identified based on eligibility for special medication reimbursement
for these conditions (Halonen et al., 2015).
The incident cases of hypertension were participants who, for the first time after Time 3, had
purchased antihypertensive medication for a minimum of 100 DDD’s (three months’
medication) or were eligible for special reimbursement for an antihypertensive drug.
6Correspondingly, the definition of incident case of diabetes was any participant who had
purchased diabetes medication for a minimum of 100 DDD’s for the first time after Time 3 or
was eligible for special reimbursement for diabetes treatment, and an incident case of
dyslipidemia was any participant who had purchased statins for a minimum of 100 DDD’s for
the first time after Time 3. Subjects with hypertension, dyslipidemia, and diabetes identified
by these criteria have previously shown to be 1.7 to 2.4 (95% CIs ranging between 1.3 and 3.7)
times more likely to have a definite cardiovascular event (Halonen et al., 2015). The number
of incident cases of hypertension, dyslipidemia, diabetes, and obesity at Time 4 were used as
the outcome (Figure 2).
Covariates. We included demographic factors (age, sex, and education), alcohol consumption,
smoking status and medical conditions (depression, cancer, asthma and rheumatic disorder) as
covariates because they are potential confounders for the association between physical activity
and the outcomes (Bauman et al., 2012). The covariates were taken from Time 3, which is the
start of the follow-up for the outcomes. Age and sex of the participants were obtained from the
employers’ registers. Information about the participants’ highest educational degree was
obtained from Statistics Finland and it was used as a three-class variable for individual
socioeconomic status: low (≤9 years of education), intermediate (>9 to ≤12 years) and high
(>12 years). High alcohol intake was indicated by self-reported average consumption of more
than 288 g/week of pure alcohol for men and 192 g/week for women or having passed out due
to high alcohol consumption at least once during the past 12 months. Self-reported smoking
status was derived from the survey and dichotomized into current smoker and current non-
smoker. Information on depression was based on the Finnish Prescription Register kept by the
Social Insurance Institution of Finland (SII) (ATC code N06A). Other chronic medical
conditions were obtained from nationwide registers: asthma and rheumatic disorder based on
Drug Reimbursement Register by SII and cancer based on the Finnish Cancer Registry. For the
analyses, participants were categorized as having no medical conditions or having ≥1 medical
conditions (depression, cancer, asthma, and/or rheumatic disorder).
Statistical analysis. We used cumulative logistic regression analysis to estimate the
association between change in physical activity levels from baseline (mean of Time 1 and 2)
to Time 3 and the number of incident cardiometabolic risk factors at Time 4. The results were
expressed as cumulative odds ratios (cORs) and their 95% confidential intervals (CIs). We
stratified all analyses by the baseline activity levels (low, moderate or high), using those who
did not change their activity level between baseline and Time 3 as reference groups. We also
7examined the association between change in physical activity levels and the 4-year incidence
of specific risk factors (hypertension, dyslipidemia, obesity, and diabetes) separately in the
three baseline activity levels by using logistic regression analysis for each of the outcomes. We
examined the interactions between sex and all cardiometabolic risk factors and their sum on
changes in physical activity. The sex interaction was suggestive only for hypertension
(P=0.09), but not with other risk factors (sum of cardiometabolic risk factors, P=0.37;
dyslipidemia, P=0.80; obesity, P=0.65; diabetes, P=0.48). Thus, we decided to conduct all
analyses combined for men and women. P for trend was analyzed with logistic regression for
each baseline activity level by using the physical activity level at Time 3 as a continuous
variable. All analyses were adjusted for age, sex, education, smoking status, alcohol
consumption, and medical conditions at Time 3. The SAS 9.4 Statistical Package was used for
all of the analyses (SAS Institute Inc., Cary, NC).
Results
Characteristics of the study population at the beginning of the follow-up (Time 3) by baseline
physical activity levels are presented in Table 1. Mean age of the study population was 50.5
(SD 8.7) years, 85% of them being women, 8% having low education and 21% medical
conditions. Of the participants, 24% had low (mean activity 8.8 (SD 3.6) MET-hours/week),
37% moderate (mean activity 21.6 (SD 4.4) MET-hours/week), and 39% high (mean activity
49.9 (SD 20.9) MET-hours/week) baseline physical activity level. By Time 3, 22% had
increased and 27% had decreased their physical activity. At Time 4, 87% of the participants
had no risk factors (n=13,648), 11% had one (n=1,757) and 1.5% (n=229) had more than one
of the risk factors.
The associations between change in physical activity from baseline to Time 3 and the
accumulation of incident cardiometabolic risk factors at Time 4 are shown in Table 2.
Compared to those who remained at low activity level, participants who increased their activity
were less likely to have cardiometabolic risk factors at Time 4 (cOR=0.73, 95% CI 0.59-0.90
for low-to-moderate and cOR=0.67, 95% CI 0.49-0.89 for low-to-high, P for trend 0.0007).
The mean increase in physical activity from low to moderate level was 10.6 (SD 5.1) MET-
hours/week and from low to high level 31.7 (SD 16.2) MET-hours/week. Those participants
who had a high baseline physical activity level but decreased their physical activity to low level
by Time 3 were more likely to accumulate cardiometabolic risk factors by Time 4 compared to
8those who remained at high activity level (cOR=1.60 (95% CI 1.27-2.01). The mean decrease
in physical activity from high to low activity level was 35.0 (SD 17.2) MET-hours/week.
Table 3 shows the associations between change in physical activity and 4-year incidence of
hypertension, dyslipidemia, obesity, and diabetes separately. Compared to those who remained
at low activity level, participants who increased their activity level from low to moderate
lowered the risk for incident obesity (OR=0.69, 95% CI 0.50-0.95). In addition, there was a
trend towards lower risk of hypertension and diabetes with increasing physical activity from
low baseline activity level (P for trend <0.05) and a trend towards higher risk of dyslipidemia,
obesity and diabetes with decreasing physical activity from high baseline activity level (P for
trend <0.05). Participants who decreased their activity level from high to low were 1.4 to 1.7
times more likely to develop hypertension (OR=1.41, 95% CI 1.03-1.92), dyslipidemia
(OR=1.71, 95% CI 1.00-2.90), and obesity (OR=1.67, 95% CI 1.19-2.34), and four times more
likely to develop diabetes (OR=4.27, 95% CI 1.06-17.16) over the next four years when
compared to those who remained at high activity level.
Discussion
In this large prospective cohort study with repeated measures of physical activity over eight
years, we found that adults with an increase in physical activity from low to moderate or high
had a lower likelihood of accumulating cardiometabolic risk factors than those with unchanged
low physical activity level. This association followed a dose-response pattern with greater
increases being related to greater benefits. In contrast, participants who decreased their physical
activity from high to low level had higher odds of developing new cardiometabolic risk factors
when compared to those who remained at high physical activity level.
In our study, half of the participants changed their baseline physical activity level by Time 3.
This is in line with the proportions found in the previous studies on change in physical activity,
although they have been based on only two measurement points (Aadahl et al., 2009; Almeida
et al., 2014; Balkau et al., 2006; Byberg et al., 2001). We found that increase in physical activity
among the less active individuals lowered the likelihood for accumulating cardiometabolic risk
factors in a dose-response manner when compared to those who remained physically inactive.
This suggests that even a modest (~10 MET-hours/week) increase in leisure-time or
commuting physical activity may be sufficient in reducing the risk of obesity and other
9cardiometabolic risk factors. Although the differences between activity change categories were
not all significant, there was a tendency towards lower risk of hypertension, obesity and
diabetes with increasing physical activity from low baseline activity level. Thus, our results
complement previous findings suggesting that an increase in physical activity over time is
associated with improved blood glucose, reduced weight and waist circumference (Aadahl et
al., 2009; Balkau et al., 2006; Byberg et al., 2001; DiPietro et al., 2004).
The findings of this study add evidence on dose-response relationship between amount of
physical activity and cardiometabolic health (Eljsvogels and Thompson, 2015; Physical
Activity Guidelines Advisory Committee, 2008; Powell et al., 2011), and highlight that cardio-
metabolically healthy individuals who are less physically active can reduce their future health
risk by only modestly increasing their physical activity level. However, as chronic diseases
develop slowly, physical activity should be regular and sufficient over time in order to offer
these health benefits. For example, in the Uppsala cohort (Byberg et al., 2009), men who
increased their physical activity to a high level over 10 years halved their mortality risk to a
level on a par with those who had unchanged high activity level. The reduction in mortality
risk by an increase in physical activity was similar to that of smoking cessation in the same
cohort.
The participants who decreased their high baseline activity level to low level by Time 3 were
more likely to accumulate incident cardiometabolic risk factors over the next four years
compared to those who remained at high activity level. A decrease from high to low physical
activity level increased the risk for incident diabetes markedly and almost doubled the risk for
other risk factors. Although it is plausible that decrease in physical activity over time increases
cardiometabolic risk (Booth et al., 2012; Byberg et al., 2001; Petersen et al., 2012;
Wannamethee et al., 1998), chronic medical conditions, which are associated to both physical
activity and cardiometabolic risk can be an alternative explanation for the link. Thus, we have
adjusted our analysis for depression, cancer, asthma and rheumatic disorder. Because
controlling for chronic medical conditions did not markedly impacted the results, reversed
causality is an unlikely alternative explanation for the link.
Strengths and weaknesses of the study. Strengths of this study include information on
repeatedly measured duration, frequency and intensity of leisure-time and commuting physical
activity from a large sample of over 15,000 cardio-metabolically healthy individuals over an
extended time period. Because baseline assessment used data on two measurements with a 4-
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year interval, we were able to minimize biases due to regression to the mean (10). Moreover,
all cardiometabolic risk factors, except obesity, were defined based on linkage to reliable
national health registers.
Self-report of physical activity can be regarded as a weakness of the study although self-
reported activity is frequently used to separate participants into different activity categories in
large population studies (Bauman et al., 2009). The chosen cut-point of physical activity ≥14
MET-hours per week has previously been shown to associate with health outcomes in large
epidemiological studies (Arem et al., 2015; Moore et al., 2012; Tanasescu et al., 2000).
However, some of the participants in the “low activity” group met the current physical activity
recommendations. Furthermore, measurement of physical activity did not include occupational
physical activity, thus we could not assess total amount of physical activity. Although there
were more women and a higher proportion of highly educated participants at the study
population compared to the eligible population at Time 1, the test of interactions for the
association between change in physical activity and the sum of incident cardiometabolic risk
factors by sex (P=0.37) and by education (P=0.71) was non-significant, suggesting that any
difference in the sex distribution or educational attainment between the analytic and eligible
population is an unlikely source of important bias in this study. The study population is
representative of the Finnish public sector employees, however, the results may not necessarily
be generalizable to other sectors or non-working populations.
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Conclusions
To conclude, the present study showed that even a modest increase from low activity level
over time is enough to reduce risk of obesity and accumulation of incident cardiometabolic
risk factors among healthy adults.
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Figure 1. Flow chart of the selection of the analytical sample. Finnish Public Sector study
1997–2013.
Figure 2. Study design. Finnish Public Sector study 1997–2013.
